Deficiency of the Tangier Disease Gene Abca1 Is Associated With Microglial Defects in Mice

Tomas Celis1, Oriana Ramírez-Herrera1, Myrna Barraza1

  • 1Instituto de Ciencias de la Salud, Universidad de O´Higgins, Rancagua, Chile.

Insights

Cholesterol transporters ATP-binding cassette transporter A1 (ABCA1) and scavenger receptor class B type 1 (SR-B1) impact microglial development. Their inactivation affects microglial density and morphology, suggesting a role in neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology
  • Lipid Metabolism

Background:

  • Microglia, the primary immune cells of the central nervous system, are crucial for brain homeostasis.
  • Microglial development and maturation involve complex signaling pathways, with potential roles for lipid metabolism.
  • Cholesterol transport is vital for cell function, but its specific role in microglial development is not fully understood.

Purpose of the Study:

  • To investigate the impact of inactivating cholesterol transporters ABCA1 and SR-B1 on microglial development in mice.
  • To determine if ABCA1 and SR-B1 are expressed in microglia and regulated during neurodegeneration.
  • To elucidate the role of lipid transport in maintaining microglial identity and its potential link to neurodegenerative diseases.

Main Methods:

  • Analysis of public datasets to assess the expression of ABCA1 and SR-B1 in microglia.
  • Evaluation of microglial density and morphology in mice with inactivated ABCA1 and/or SR-B1.
  • Comparison of microglial development across different developmental stages and brain regions.

Main Results:

  • Both ABCA1 and SR-B1 are expressed in microglia and show differential regulation in neurodegeneration models.
  • Inactivation of ABCA1 or SR-B1 led to distinct alterations in microglial density and/or morphology.
  • These effects varied depending on the specific transporter, developmental stage, and brain region examined.

Conclusions:

  • Proper lipid transport via ABCA1 and SR-B1 is essential for maintaining microglial homeostatic identity.
  • Dysregulation of cholesterol transport mechanisms may contribute to the pathogenesis of neurodegenerative diseases.
  • Targeting lipid metabolism pathways could offer novel therapeutic strategies for neurological disorders.